Guardian Partners’s Microbot Medical MBOT Stock Holding History

Guardian Partners’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.9K	Buy	+2,000	New	+$4.08K	﹤0.01%	362

Other funds holding MBOT

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.21B AUM 19.13% 1-Year Est. Return

BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Asset Planning Inc Cypress, California $154M AUM 25.18% 1-Year Est. Return

Guardian Partners's MBOT Position: Q2 2026 in Review

Guardian Partners opened a new position in Microbot Medical (MBOT) in Q2 2026: 2,000 shares worth $3.9K. The stake represents ﹤0.01% of the portfolio and ranks #362 among its holdings.

18 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

Guardian Partners held 2,000 shares of Microbot Medical worth $3.9K as of Q2 2026.
Microbot Medical was a new Guardian Partners position in Q2 2026.
Microbot Medical made up ﹤0.01% of Guardian Partners's portfolio in Q2 2026, its #362 holding.
18 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Guardian Partners's 13F filing for Q2 2026, filed 29 Jul 2026.